4.6 Article

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Oncology

Use of risk-based cervical screening programs in resource-limited settings

Rebecca B. Perkins et al.

Summary: Cervical cancer screening and management in resource-limited settings can be optimized by adopting a risk-based approach. This includes using effective screening methods to separate low-risk from high-risk patients, directing resources to populations at highest cancer risk, utilizing HPV testing via self-sampling, improving risk stratification with HPV genotyping, and implementing automated visual evaluation with artificial intelligence to further enhance risk stratification. Risk-based screening and management allows for targeted triage and treatment while minimizing interventions in lower risk patients in resource-limited settings.

CANCER EPIDEMIOLOGY (2023)

Article Oncology

Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore

Brandon Chua et al.

Summary: Extended genotyping (XGT) for cervical cancer screening, which identifies human papillomavirus (HPV) genotypes beyond HPV16 and HPV18, can provide risk stratification for clinical management. A study in Singapore compared the resource use, cost, and quality-adjusted life years (QALY) of XGT to partial genotyping (PGT). The results showed that XGT was cost-effective, utilized fewer resources, and provided a risk-based approach compared to PGT. This analysis, conducted in an Asian context, could guide the use of XGT in Asia.

CANCERS (2023)

Article Medicine, General & Internal

Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis A Nationwide Population-Based Cohort Study With Sibling Comparison Design

Wei He et al.

Summary: A study found that women diagnosed with CIN 3 have a higher risk of adverse pregnancy outcomes, including preterm birth, infection-related outcomes, and early neonatal death. However, this risk decreases over time.

ANNALS OF INTERNAL MEDICINE (2022)

Article Oncology

Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States

Alexandra Bukowski et al.

Summary: This study assessed the role of different HPV genotypes in the progression of high-grade cervical intraepithelial neoplasia (CIN2+). The results showed that non-16/18 HPV types are associated with differential rates of CIN2+ progression, with HPV16, 33, and 58 exhibiting the highest risks.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Medicine, General & Internal

The IARC Perspective on Cervical Cancer Screening

Veronique Bouvard et al.

Summary: This article reviews the best methods of screening for cervical cancer, with HPV nucleic acid testing being superior whether used alone or in combination with other methods.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Infectious Diseases

2020 list of human papillomavirus assays suitable for primary cervical cancer screening

Marc Arbyn et al.

Summary: This study updated the list of high-risk HPV assays that fulfill the international validation criteria, with only 11 DNA assays meeting the requirements for cervical cancer screening using clinician-collected specimens, while other tests partially fulfilled the validation criteria.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

Article Medicine, General & Internal

Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial

K. Miriam Elfstrom et al.

Summary: This study found that primary HPV-based screening was acceptable and effective when compared to cytology-based screening in a real-life setting, with comparable rates of participation, referral, and detection.

PLOS MEDICINE (2021)

Article Oncology

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

Laila Sara Arroyo Muhr et al.

BRITISH JOURNAL OF CANCER (2020)

Article Oncology

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer

Camilla Lagheden et al.

BRITISH JOURNAL OF CANCER (2018)

Article Public, Environmental & Occupational Health

Registry-based assessment of the status of cervical screening in Sweden

K. Miriam Elfstrom et al.

JOURNAL OF MEDICAL SCREENING (2016)

Article Virology

Need for expanded HPV genotyping for cervical screening

Jack Cuzick et al.

PAPILLOMAVIRUS RESEARCH (2016)

Letter Oncology

Judging the carcinogenicity of rare human papillomavirus types

Jean-Damien Combes et al.

INTERNATIONAL JOURNAL OF CANCER (2015)

Article Oncology

Are 20 human papillomavirus types causing cervical cancer?

Marc Arbyn et al.

JOURNAL OF PATHOLOGY (2014)

Article Infectious Diseases

A cross sectional study of HPV type prevalence according to age and cytology

Elena Argyri et al.

BMC INFECTIOUS DISEASES (2013)

Article Medicine, General & Internal

Screening and cervical cancer cure: population based cohort study

Bengt Andrae et al.

BMJ-BRITISH MEDICAL JOURNAL (2012)

Article Oncology

Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia Grade 3

Philip E. Castle et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)

Article Medicine, General & Internal

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

Peter Sasieni et al.

BMJ-BRITISH MEDICAL JOURNAL (2009)

Article Medicine, General & Internal

Human papillomavirus and papanicolaou tests to screen for cervical cancer

Pontus Naucler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Medicine, General & Internal

Disease impact number and population impact number: population perspectives to measures of risk and benefit

RF Heller et al.

BRITISH MEDICAL JOURNAL (2000)